Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex

Clinical trial NCT01730209 · UNKNOWN

Trial details

NCT number: NCT01730209
Sponsor: Erasmus Medical Center
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Tuberous Sclerosis Complex TSC Related Cognitive Disability TSC Related Autism TSC Related Learning Problems

Start date: 2012-11-01
Primary completion: 2015-11-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.